Wai Chun Bio-Technology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ka Chun Lam
Chief executive officer
HK$727.0k
Total compensation
| CEO salary percentage | 98.5% |
| CEO tenure | 7.3yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.1yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -HK$14m |
| Sep 30 2023 | n/a | n/a | -HK$15m |
| Jun 30 2023 | HK$727k | HK$716k | -HK$15m |
Compensation vs Market: Ka Chun's total compensation ($USD92.84K) is below average for companies of similar size in the Hong Kong market ($USD233.25K).
Compensation vs Earnings: Insufficient data to compare Ka Chun's compensation with company performance.
CEO
Ka Chun Lam (31 yo)
7.3yrs
Tenure
HK$727,000
Compensation
Mr. Ka Chun Lam is MD, CEO & Executive Chairman of Wai Chun Bio-Technology Limited from November 01, 2023. He was MD & Executive Director of Wai Chun Bio-Technology Limited from March 13, 2023. He is Execu...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Chairman | 1.1yrs | HK$727.00k | no data | |
| Independent Non-Executive Director | 3.4yrs | HK$120.00k | no data | |
| Independent Non Executive Director | no data | no data | no data |
1.1yrs
Average Tenure
54yo
Average Age
Experienced Board: 660's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.